Reaction
Polydactyly reporting signals
As of the last recalculation, Polydactyly appears in 1,139 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 119.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nevirapine | 56 | 119.2 | 120.0 |
| Abacavir Sulfate | 56 | 110.4 | 111.1 |
| Zidovudine | 66 | 95.7 | 96.2 |
| Lopinavir And Ritonavir | 56 | 79.4 | 79.7 |
| Labetalol | 51 | 73.2 | 73.4 |
| Darunavir | 54 | 68.4 | 68.7 |
| Ritonavir | 90 | 61.0 | 61.2 |
| Lamivudine Oral | 75 | 57.9 | 58.1 |
| Lamivudine | 85 | 54.2 | 54.4 |
| Efavirenz | 27 | 45.3 | 45.4 |
| Atazanavir | 30 | 39.2 | 39.2 |
| Ritonavir 100 Mg | 28 | 35.1 | 35.2 |
| Tenofovir Disoproxil Fumarate Tablets | 15 | 32.2 | 32.2 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 70 | 29.8 | 29.9 |
| Raltegravir | 26 | 29.4 | 29.5 |
| Levetiracetam In Sodium Chloride | 96 | 24.6 | 24.7 |
| Levetiracetam Oral | 96 | 24.6 | 24.7 |
| Levetiracetam Injection | 96 | 24.6 | 24.7 |
| Lamotirigine | 84 | 23.1 | 23.1 |
| Lamotrigine Extended-Release | 84 | 23.1 | 23.1 |
| Lamotrigine Chewable Dispersible | 84 | 23.1 | 23.1 |
| Lacosamide | 44 | 22.4 | 22.5 |
| Nifedipine | 53 | 21.5 | 21.5 |
| Valproic Acid | 34 | 20.3 | 20.3 |
| Valproate Sodium | 19 | 17.1 | 17.1 |
| Levetiracetam | 112 | 16.9 | 16.9 |
| Tenofovir Disoproxil Fumarate | 29 | 16.4 | 16.4 |
| Dolutegravir Sodium | 8 | 16.3 | 16.3 |
| Misoprostol | 8 | 15.1 | 15.1 |
| Lamotrigine | 93 | 14.0 | 14.0 |
| Carbamazepine | 44 | 12.4 | 12.4 |
| Clobazam | 11 | 8.3 | 8.3 |
| Alpelisib | 3 | 6.3 | 6.3 |